A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

NCT04735575 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Company's resource optimization and product's development change

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions

BIOLOGICAL: EMB-06

Sponsor

Shanghai EpimAb Biotherapeutics Co., Ltd.